A new partnership between the NHS, academia, government, and industry has launched in a bid to accelerate clinical trials and treatment for chronic kidney disease.
Scotland’s cabinet secretary for health Neil Gray has said the project is a “shining example” of how public-private collaboration can benefit health studies. The collaborators include:
- Scottish Government
- NHS Scotland
- AstraZeneca
- University of Dundee
- University of Glasgow
The partnership will support treatment development, build infrastructure and enhance expertise in renal clinical trial delivery.
“This project’s ‘triple helix’ approach is a shining example of how collaboration between the NHS, Scottish Government, academia and industry can accelerate health studies,” said Gray. “As we navigate the complex issue of chronic kidney disease, our commitment to patient-centred research remains unwavering.”
Chronic kidney disease impacts more people in Scotland than cancer, with treatment including a transplant or dialysis. Over the next decade, the demand for kidney transplants and dialysis in Scotland is estimated to cost the economy more than £1bn.
Professor Dame Anna Dominiczak, chief health scientist at the Scottish Government, said: “We must all work together to improve the outcomes and life circumstances for people living with kidney disease; and this partnership enables the fusion of medical expertise, knowledge, and insight from across NHS, academia, and industry.”
Prevention is one of the key aims to the partnership, which is becoming an increasingly prominent priority for the health service as it continues to develop proactive policies rather than reactive.
In the latest edition of the National Health Executive digital magazine, several exclusive pieces were written for the Prevention section, including how PET scanning can transform patient outcomes from the Medicines Discovery Catapult and how sexual health needs a national strategy from the British Association for Sexual Health and HIV.
Pieces on why technology can offer a lifeline against superbugs and how failing can be a precursor to success are also featured.
Image credit: iStock
![[Left to right] Prof. Ronan Killeen - Consultant Radiologist at St. Vincent's Private Hospital, Andy Wilks - Head of Enterprise Services for Siemens Healthineers Great Britain and Ireland, Edel O’Keeffe - Director of Finance at St. Vincent's Private Hospital, Ghada Trotabas - Managing Director of Siemens Healthineers Great Britain and Ireland, Brian Fitzgerald - Chief Executive Officer of St. Vincent's Private Hospital with Grania Heal – Country Head for Ireland at Siemens Healthineers, and Rob Ruttledge](/sites/nhe/files/styles/teaser/public/2024-09/Press%20release%20image-24.jpg?itok=gHKP-rtG)
